120 related articles for article (PubMed ID: 2205380)
1. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.
Rosolen A; Whitesell L; Ikegaki N; Kennett RH; Neckers LM
Cancer Res; 1990 Oct; 50(19):6316-22. PubMed ID: 2205380
[TBL] [Abstract][Full Text] [Related]
2. Antisense inhibition of N-myc reduces cell growth but does not affect c-myc expression in the neuroepithelioma cell line CHP100.
Rosolen A; Whitesell L; Ikegaki N; Kennett R; Neckers LM
Prog Clin Biol Res; 1991; 366():29-36. PubMed ID: 2068146
[No Abstract] [Full Text] [Related]
3. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
4. Antisense inhibition of CHP100 C-myc expression results in reduced in vitro growth kinetics and loss of in vivo tumorigenesis.
Rosolen A; Toretsky J; Neckers L
Prog Clin Biol Res; 1994; 385():95-101. PubMed ID: 7972241
[No Abstract] [Full Text] [Related]
5. Modification of myc gene amplification in human somatic cell hybrids.
Iman DS; Shay JW
Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
[TBL] [Abstract][Full Text] [Related]
6. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
7. N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system.
Rouah E; Wilson DR; Armstrong DL; Darlington GJ
Cancer Res; 1989 Apr; 49(7):1797-801. PubMed ID: 2924321
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Myc targets in c-myc and N-myc induced human tumors.
Ben-Yosef T; Yanuka O; Halle D; Benvenisty N
Oncogene; 1998 Jul; 17(2):165-71. PubMed ID: 9674700
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
[TBL] [Abstract][Full Text] [Related]
10. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
Prins J; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
[TBL] [Abstract][Full Text] [Related]
11. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
Li BD; Budnick RM; Russo CA; Anderson GR; Stewart CC
J Surg Res; 1995 Oct; 59(4):485-92. PubMed ID: 7564322
[TBL] [Abstract][Full Text] [Related]
12. [Effects of antisense N-myc gene on nerve growth factor-induced differentiation of neuroblastoma cell line].
Chen J; Liu T; Zhe X; Jiang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun; 21(3):197-202. PubMed ID: 12569653
[TBL] [Abstract][Full Text] [Related]
13. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells.
Yu BW; Nguyen D; Anderson S; Allegra CA
Anticancer Res; 1997; 17(6D):4407-13. PubMed ID: 9494542
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of the proto-oncogene, c-myc, in human neuroblastoma cells by reversible inhibition of cell growth.
Fukuchi K; Tomoyasu S; Watanabe K; Suzuki H; Kaetsu T; Takagi Y; Tsuruoka N; Gomi K
Anticancer Res; 1991; 11(6):1967-73. PubMed ID: 1776829
[TBL] [Abstract][Full Text] [Related]
15. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
[TBL] [Abstract][Full Text] [Related]
16. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of epidermal growth factor and fetal calf serum in human endometrial carcinoma RL95-2 cells.
Sallot M; Lascombe I; Bermont L; Jouvenot M
Anticancer Res; 1997; 17(5A):3499-504. PubMed ID: 9413194
[TBL] [Abstract][Full Text] [Related]
18. Antisense suppression of N-myc expression inhibits the transdifferentiation of neuroectoderm tumor cell lines.
Whitesell L; Rosolen A; Neckers LM
Prog Clin Biol Res; 1991; 366():45-54. PubMed ID: 2068159
[No Abstract] [Full Text] [Related]
19. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
[TBL] [Abstract][Full Text] [Related]
20. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
